Sequenom, Inc. Announces Date Of Third Quarter 2013 Financial Results And
SAN DIEGO, Oct. 24, 2013
SAN DIEGO, Oct. 24, 2013 /PRNewswire/ --Sequenom, Inc. (NASDAQ: SQNM), a life
sciences company providing innovative diagnostic testing and genetic analysis
solutions, today announced it will report financial results for the third
quarter of 2013 after closing of the NASDAQ Global Market on Thursday,
November 7, 2013.
A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and
other members of senior management will take place on the same day at 5:00 pm
EST (2:00 pm PST) and will be webcast live on the Sequenom Web site.
To access the live teleconference call, dial 877-883-0383 in the U.S. and
Canada, and 412-902-6506 for other international callers. Please use code
1655358. If you are unable to listen to the live webcast, a teleconference
replay will be available through Friday, November 29, 2013. Interested parties
can access the replay by dialing 877-344-7529 or 412-317-0088 internationally
and entering the conference number 10035907.
The conference call webcast is accessible through the "Investors" section of
the Sequenom Web site at http://www.sequenom.com/invest.An online replay will
be available following the initial broadcast until Friday, November 29, 2013.
Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to
improving healthcare through revolutionary genomic and genetic analysis
solutions. Sequenom develops innovative technology, products and diagnostic
tests that target and serve discovery and clinical research, and molecular
diagnostic markets. The company was founded in 1994 and is headquartered in
San Diego, California. Sequenom maintains a Web site at
http://www.sequenom.com to which Sequenom regularly posts copies of its press
releases as well as additional information about Sequenom. Interested persons
can subscribe on the Sequenom Web site to email alerts or RSS feeds that are
sent automatically when Sequenom issues press releases, files its reports with
the Securities and Exchange Commission or posts certain other information to
the Web site.
SOURCE Sequenom, Inc.
Contact: Paul Maier, CFO, Sequenom, Inc., 858-202-9028,
email@example.com, or Rachel Kennedy, Media Contact, Chandler
Chicco Agency, 858-449-9575, firstname.lastname@example.org
Press spacebar to pause and continue. Press esc to stop.